Insulin analogues with an acyl and aklylene glycol moiety

Details for Australian Patent Application No. 2008288413 (hide)

Owner Novo Nordisk A/S

Inventors Kjeldsen, Thomas Borglum; Kodra, Janos Tibor; Garibay, Patrick William; Jakobsen, Palle; Hoeg-Jensen, Thomas; Gram, Dorte Xenia; Tagmose, Tina Moller; Madsen, Peter

Agent Shelston IP

Pub. Number AU-A-2008288413

PCT Pub. Number WO2009/022013

Priority 07114386.1 15.08.07 EP

Filing date 15 August 2008

Wipo publication date 19 February 2009

International Classifications

C07K 14/62 (2006.01) Peptides having more than 20 amino acids

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/022013 Priority application(s): WO2009/022013

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008288416-LED lighting device for growing plants

2008288410-Pharmaceutical composition comprising a SGLT2 inhibitor in combination with a DPP-IV inhibitor